business
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason
Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop